GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organogenesis Holdings Inc (FRA:2PQ) » Definitions » Cash Flow from Others

Organogenesis Holdings (FRA:2PQ) Cash Flow from Others : €30.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Organogenesis Holdings Cash Flow from Others?

Organogenesis Holdings's cash flow from others for the three months ended in Jun. 2024 was €21.0 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2024 was €30.0 Mil.


Organogenesis Holdings Cash Flow from Others Historical Data

The historical data trend for Organogenesis Holdings's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organogenesis Holdings Cash Flow from Others Chart

Organogenesis Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only 3.57 4.96 14.36 15.91 8.79

Organogenesis Holdings Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.87 4.08 -0.76 5.76 20.97

Organogenesis Holdings Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €30.0 Mil.

Organogenesis Holdings Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Organogenesis Holdings's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Organogenesis Holdings Business Description

Traded in Other Exchanges
Address
85 Dan Road, Canton, MA, USA, 02021
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Organogenesis Holdings Headlines

No Headlines